Does Cannabis Withdrawal Mimic Depressive Symptoms?

PostedFebruary 25, 2026

UpdatedFebruary 25, 2026

ByMy Patient Advice

Author: Dr. Clarissa Morton, PharmD

Some studies suggest that cannabis withdrawal in depression can overlap with the very symptoms people are trying to manage. Individuals who reduce or stop cannabis after regular use may experience low mood, irritability, or sleep problems. These withdrawal symptoms can resemble or intensify depression, making it difficult to tell whether the cause is the condition itself or the effects of discontinuation.

Researchers highlight that withdrawal is more common in those who use cannabis frequently or in high doses. For people with depression, this can create a cycle where stopping cannabis temporarily worsens mood, leading to resumed use.

Recognising The Overlap

Evidence on cannabis withdrawal in depression shows that certain effects share features with depressive episodes. Understanding these overlaps can help patients and clinicians manage symptoms more effectively.

Withdrawal Symptoms

Common withdrawal symptoms include insomnia, irritability, fatigue, and loss of appetite. These often appear within a few days of stopping use and may last one to two weeks.

Mood Changes

Many individuals also report mood changes, such as heightened sadness or loss of interest. In patients with depression, these changes can mimic a relapse, even when they are linked to withdrawal.

Discontinuation Effects

Studies highlight discontinuation effects like restlessness and anxiety, which further complicate the distinction between withdrawal and depressive symptoms. This overlap can delay treatment adjustments or create uncertainty in care.

In summary, cannabis withdrawal in depression can produce symptoms that resemble or worsen existing mood problems. Recognising this overlap is important for managing both conditions safely and effectively.

For individuals worried about withdrawal or symptom relapse, providers like LeafEase can offer supportive consultations to guide safe discontinuation and treatment planning.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression.

Dr. Clarissa Morton, PharmD

Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.